COVID-19 pediatric vaccine authorization, FDA authority, and individual misperception of risk

Public commentary in response to the vaccine advisory groups’ meeting with the US Food and Drug Administration over the Emergency Use Authorization (EUA) of the COVID-19 vaccine in children (5-11) displayed overwhelming opposition to the EUA and vaccine-risk misperceptions. (April 19, 2024)